Developmental anomalies and oxidative stress responses in zebrafish (danio rerio) following embryonic exposure to human pharmaceuticals by Aderemi, Adeolu O. et al.
Developmental anomalies and oxidative stress responses in zebrafish (danio rerio)
following embryonic exposure to human pharmaceuticals




Publisher's PDF, also known as Version of record
Link to publication in ResearchOnline
Citation for published version (Harvard):
Aderemi, AO, Hunter, C, Pahl, O, Roberts, J & Shu, X 2020, 'Developmental anomalies and oxidative stress
responses in zebrafish (danio rerio) following embryonic exposure to human pharmaceuticals', International
Journal of Toxicology and Environmental Health, vol. 5, no. 1, pp. 109-125.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please view our takedown policy at https://edshare.gcu.ac.uk/id/eprint/5179 for details
of how to contact us.
Download date: 12. Sep. 2020
Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Rerio)
Following Embryonic Exposure to Human Pharmaceuticals.
Aderemi, Adeolu; Hunter, Colin; Pahl, Ole; Roberts, Joanne; Shu, Xinhua
Published in:




Publisher's PDF, also known as Version of record
Link to publication in ResearchOnline
Citation for published version (Harvard):
Aderemi, A, Hunter, C, Pahl, O, Roberts, J & Shu, X 2020, 'Developmental Anomalies and Oxidative Stress
Responses in Zebrafish (Danio Rerio) Following Embryonic Exposure to Human Pharmaceuticals.', International
Journal of Toxicology and Environmental Health, vol. 4, no. 2, pp. 109-125.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please view our takedown policy at https://edshare.gcu.ac.uk/id/eprint/5179 for details
of how to contact us.
Download date: 11. Aug. 2020









Developmental Anomalies and Oxidative Stress Responses 
in Zebrafish (Danio Rerio) Following Embryonic Exposure 
to Human Pharmaceuticals 
 
1*Aderemi O. Adeolu, 2Hunter Colin, 3Pahl Ole, 4Roberts Joanne, 5Shu Xinhua 
1,2,3,4School of Engineering and Built Environment, Glasgow Caledonian University, United Kingdom 
5Department of Life Sciences, Glasgow Caledonian University, United Kingdom 
 
The discharge of human pharmaceuticals via wastewater treatment plants represents a major 
threat to non-target aquatic organisms since they are continually exposed throughout their 
lifespan. The individual effects of the anaesthetic, lidocaine; the cytostatics, ifosfamide and 
cyclophosphamide; and the antimicrobials, sulfamethoxazole, amoxicillin and erythromycin on 
24 hpf (hours post fertilization) zebrafish (Danio rerio) following a 96-h exposure was investigated 
by evaluating embryonic development, catalase (CAT) enzyme activity, and the gene expressions 
of CAT, cytosolic superoxide dismutase (SOD1), and mitochondrial superoxide dismutase 
(SOD2). Lidocaine, cyclophosphamide and sulfamethoxazole induced neurotoxicity (scoliosis, 
tail malformation) and cardiotoxicity (pericardial edema, bradycardia) in the zebrafish which 
correlate with their adverse effects in mammals. These observations were linked to oxidative 
stress as indicated by the significant alteration of CAT activity and amounts of transcripts of 
SOD1, SOD2, and CAT. The CAT activity and gene expressions of the antioxidants were 
significantly upregulated at sublethal and levels of ifosfamide, lidocaine, cyclophosphamide, and 
erythromycin non-toxic to embryonic development in this study which suggest that these 
antioxidants may play a role in the prevention of teratogenicity in the larvae. The multi-level effect 
approach adopted in this study provides a better understanding of the mechanisms of toxicity 
employed by lidocaine, cyclophosphamide and sulfamethoxazole towards zebrafish. This study 
shows the importance of evaluating stress biomarkers and emphasizes the need for chronic 
studies in assessing pharmaceutical effects on aquatic organisms. 
 





The discharge of human pharmaceuticals via wastewater 
is an ongoing concern since they represent a long-term 
threat to the non-target aquatic organisms. Although, 
industrial and municipal wastewaters undergo purification 
in wastewater treatment plants (WWTP), complete 
removal of many pharmaceuticals is not ensured (Kostich 
et al., 2014; Fernandez-Lopez et al., 2016) so significant 
concentrations of some pharmaceuticals can occur in 
effluents, groundwater, surface waters and also in drinking 
water (Yang et al., 2017; Comber et al., 2018).  
 
The potential impact of any toxicant in ecosystems 
requires the observation of effects at different levels of 
biological organization (Lemos et al., 2010; Ferreira et al., 
2015). Many of the studies on the ecotoxic effects of 
pharmaceuticals are focused on the organismal or higher 
levels. However, at such levels alone, the mechanisms of 
toxicity of the drugs are poorly understood and the 
predictive ability of measurements done at these levels is 
limited (Verslycke et al., 2004). Over the last decades, 
biomarkers at suborganismal levels have been considered 
viable measures of responses to stressors (Huggett et al., 
1992). Several biomarkers including those indicative of 
oxidative stress have been used at the molecular and 
cellular levels as efficient tools due to their sensitivity,   
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quickness, and accurate relationship between toxicant 
exposure and respective biological response (Connon et 
al., 2012; Mao et al., 2020).  
 
Xenobiotics have been shown to exert various adverse 
effects on the health of zebrafish (Albalawi et al., 2018; 
Sachett et al., 2018; Patibandla et al., 2018; Vigano et al., 
2020). Effects of ibuprofen, ketoprofen, diclofenac, 
paracetamol, fluoxetine and atenolol on zebrafish 
development and several biomarkers indicative of adverse 
effects have been investigated (Diniz et al., 2015; Xia et 
al., 2017; Nowakowska et al., 2020). Zebrafish embryos 
are an attractive model for studies of developmental 
toxicity of chemicals both for human and environmental 
risk assessment (Mesquita et al., 2017; Cassar et al., 
2019). The rapid development, large number of offspring, 
optical transparency of the embryos and availability of a 
full genome sequence are some of the advantageous 
characteristics of this model (Carlsson et al., 2013). In 
addition, pharmacologic responses of zebrafish to well-
characterized cardiotoxins are similar to responses in 
humans, making it an excellent model for cardiotoxicity 
assessment (Zhu et al., 2014).  
 
Due to the higher pharmaceutical concentrations in 
hospital effluents than other effluents, a separate 
treatment of hospital wastewater prior to discharge into the 
sewage system has been highly recommended (Verlicchi 
et al., 2012; Helwig et al., 2013). This study examined six 
individual pharmaceuticals; lidocaine LDC, 
cyclophosphamide CYC, ifosfamide IFS, 
sulfamethoxazole SUF, amoxicillin AMX, and erythromycin 
ERY selected from a wide range of pharmaceuticals 
monitored in hospital wastewater in the European Union 
funded PILLS project (Helwig et al., 2013) from which the 
present study emanated. Selection was based on their 
hospital contribution, European wide usage and 
persistence in the environment (Helwig et al., 2013). LDC, 
a local anesthetic used in dental surgery, inhibits sodium 
influxes required for the initiation and conduction of nerve 
impulses (Short et al., 1988). CYC and IFS are anticancer 
agents and act by preventing cell division by cross-linking 
DNA strands and inhibiting DNA synthesis (Zounkova et 
al., 2007). The antibacterials, SUF, ERY and AMX inhibit 
the synthesis of folic acid, protein, and cell wall in bacteria 
respectively (van der Grinten et al., 2010; Gonzalez-Pleiter 
et al., 2013; Magdaleno et al., 2015). 
 
This study was aimed at linking the selected 
pharmaceutical effects in zebrafish at the molecular and 
cellular levels to an outcome at the organismal level of 
organization, for example embryonic development, 
elucidating the mechanisms of toxicity of these 
compounds. This study was therefore carried out to 
investigate the lethal and sublethal effects of LDC, CYC, 
IFS, SUF, AMX and ERY on the embryonic development 
of 24 hpf zebrafish (Danio rerio); and the activity and gene 
expression levels of antioxidative enzymes; catalase, CAT 
and superoxide dismutases, SOD1 and SOD2.  




Stock solutions of LDC (CAS no. 137-58-6), IFS (CAS no. 
3778-73-2), CYC monohydrate (CAS no. 6055-19-2), SUF 
(CAS no. 723-46-6), ERY hydrate (CAS no. 114-07-8), and 
AMX (CAS no. 26787-78-0) purchased from Sigma with ≥ 
95% purity were prepared directly by diluting in E3 embryo 
medium (NaCl, 292 mg/L; KCl, 13 mg/L; CaCl2, 44 mg/L; 
MgSO4, 81 mg/L; and NaHCO3, 192 mg/L in deionized 
water plus 200 µL of 0.05% methylene blue for fungicidal 
effects). Stocks were kept refrigerated and protected from 
light. 
 
Zebrafish husbandry and egg collection 
 
AB strain adult zebrafish (D. rerio) reared in Glasgow 
Caledonian University Fish Facility were maintained in a 
flow-through system of carbon filtered tap-water (pH = 7.5; 
Total hardness = 150 mg/L CaCO3; conductivity = 420 
µS/cm). Temperature was kept at 28oC and the 
photoperiod was 14:10 h light: darkness. Fish were fed 
twice daily with commercial flakes as staple food 
supplemented with brine shrimps (OECD, 2006). Adult 
zebrafish were placed in the breeding tanks on the 
afternoon of the day before egg collection with each tank 
containing two females and one male. Eggs were collected 
from the different tanks within 30-60 min after natural 
mating, pooled and rinsed thoroughly and eggs were 
checked under a microscope (AR-zoom, Novex, Holland); 
unfertilized or injured and dead eggs were removed and 
discarded. Fertilized eggs were kept in an incubator at 
28oC until 24 hpf. 
 
Embryo development assay 
 
Tests were carried out in accordance with the fish embryo 
toxicity (FET) test in the OECD draft guideline (Test no. 
236; OECD, 2006). Following range finding experiments, 
where lethal concentrations were determined, fertilized 
embryos were exposed to varying concentrations of the 
pharmaceuticals (diluted in E3 medium): 0.11 to 0.89 mM 
LDC; 0.31 to 2.3 mM IFS; 0.09 to 1.58 mM SUF; 0.017 to 
0.272 mM ERY; 0.41 to 2.73 mM AMX; and 0.76 to 4.59 
mM CYC. The pharmaceutical ranges were selected to 
include sublethal concentrations with the aim of collecting 
materials for biomarker analysis. 
 
Ten 24 hpf embryos per concentration were exposed to 
the test pharmaceuticals and the control (containing E3 
medium only) in 24-well plates (BioLite, Thermo Fisher 
Scientific, UK) containing a final volume of 2 ml per well. 
Tests were performed in triplicates and exposures were 
carried out in an incubator at 28°C and run for 96 h without 
medium change. The plates were sealed with self-
adhesive foil (MicroAmp® optical adhesive film, Applied 
Biosystems, UK) to prevent evaporation. Assays were not 
done concurrently except for SUF and ERY. 
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Embryos were observed daily under a cell imaging system 
in bright field configuration (EVOS® Fluorescence Cell 
Imaging System, Life Technologies Corporation, CA, USA) 
using a magnification of 4 x for embryos and 2 x for 
hatched juvenile zebrafish. Mortality and abnormalities 
including spine deformation or scoliosis, malformation of 
the tail and tail tip, yolk sac edema, pericardial edema, 
side-laying of larvae were noted at different hpf (Table 1). 
Embryonic heartbeat in zebrafish is first detectable at 24 
hpf and is an important indicator of health (AshaRani et al., 
2008) and thus the embryos and juveniles were 
considered dead when no heartbeat was observed. In 
addition, embryo heart rate was monitored from 48 hpf 
using direct microscopic observation at 4 x or 10 x 
magnification over 60 s for a minimum of 15 embryos at 
each concentration. Hatching success was assessed at 48 
hpf, which is the average time at which zebrafish embryos 
hatch (Westerfield, 2000). The pH of control and the 
highest concentration of each pharmaceutical were 
measured at the commencement and end of the 
experiments and found to be within 0.6 units. Chemical 
analysis of exposure concentrations kept in an identical 
setup in the absence of embryos was also performed. 
Samples were taken at 0, 24, 72 and 96 h and stored at -
20oC until analysis. 
 
At 120 hpf, five to eight embryos per replicate were pooled 
together in an eppendorf tube and euthanized by the 
addition of the anaesthetic, 0.1 % MS-222 (ethyl 3-
aminobenzoate methanesulfonate, tricaine, Sigma 
Aldrich) solution (Timme-Laragy et al., 2009; Bartoskova 
et al., 2014). For enzymatic and molecular analysis, the 
euthanized zebrafish larvae were flash frozen in liquid 
nitrogen and kept at -80oC. 
 
Table 1. Endpoints observable in zebrafish embryos at different hours post fertilization 
Endpoint Description 48 hpf 72 hpf 120 hpf 
Lethal categorical     
Coagulation  Embryo is coagulated with no structures + + + 
Lack of heart beats  Embryo has no visible heartbeat + + + 
Sublethal categorical     
Tail malformation Tail is shorter than normal or curved + + + 
Tail tip malformation Tail tip is curved + + + 
Yolk sac edema Abnormal swelling of the yolk sac + + + 
Pericardial edema Abnormal swelling of the pericardial cavity + + + 
Bent spine/scoliosis Curvature or twisting of the spinal cord + + + 
Partial dechorionation Larva head is trapped in chorion + + + 
Side-laying Larvae lie on side (not actively swimming)   + 
Unhatched  Embryo alive but unhatched at the time observed + + + 
Sublethal continuous     
Heart rate Number of heart beats are counted during 1 min + + + 
hpf: hours post fertilization 
 
Enzyme extraction and protein quantitation 
 
The samples frozen for enzymological study were allowed 
to thaw on ice and then homogenised using a bead beater 
(FastPrep®-24, MP Biomedicals, France) in tubes 
containing 0.3 mL sodium phosphate buffer (50 mM, pH 
7.5) and 1 mm glass beads (BioSpec products, UK) for 60 
s at 6.5 ms-1. Proteins were extracted in 0.7 ml of the 
sodium phosphate buffer, and tubes centrifuged at 12,000 
rpm for 15 min at 4oC to separate the post mitochondrial 
supernatant (Oliveira et al., 2013) which was then 
removed, transferred to new tubes and kept at -80oC for a 
later determination of CAT activity.  Total protein content 
in the mitochondrial fraction was determined using 
Bradford’s reagent (Bradford, 1976). The absorbance was 
measured at 595 nm using bovine serum albumin as 
standard. 
 
CAT activity analysis 
 
Catalase activity was evaluated spectrophotometrically 
(UVmini-1240, SHIMADZU) by measuring the 
consumption or decrease in absorbance of H2O2 every 15 
s at 240 nm for 2 min using an extinction coefficient of 40 
mM-1cm-1 for H2O2 (Aebi, 1984). The test medium 
contained 750 µL of sodium phosphate buffer (50 mM, pH 
7.5), 100 µL of H2O2 (200 mM) (30% w/w, PERDROGEN™, 
Sigma Aldrich) and 150 µL of enzymatic extract in a final 
volume of 1 mL. The blank contained 900 µL sodium 
phosphate buffer and 100 µL H2O2.  
 
Total RNA extraction & reverse transcription 
 
Total RNA was extracted using TRI Reagent® (Sigma, UK) 
according to the manufacturer’s protocol. RNA quantity 
and quality were analyzed spectrophotometrically using a 
Nanodrop ND-1000 (Thermo Scientific, DE, USA). The 
High-Capacity cDNA synthesis kit with RNase inhibitor for 
Reverse Transcription (Applied Biosystems) was used 
according to the manufacturer’s instructions using 1 µg of 
the RNA, random primers, dNTP, reverse transcriptase, 
and RNase inhibitor and carried out in a thermal cycler 
(Applied Biosystems® 2720, UK) at 37oC for 120 min. 
Resulting cDNA was diluted to a working concentration 20 
ng/µL. 
b 
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Quantitative real-time PCR 
 
The β-actin (reference or housekeeping gene), SOD1, 
SOD2 and CAT primers, published previously (Timme-
Laragy et al., 2009; Wan and Chan, 2010), were 
purchased from Integrated DNA Technology (IDT), UK. 
Primer efficiencies were tested to ensure the 
housekeeping and target genes amplified at the same rate. 
The nucleotide sequences employed are listed in Table 2.  
A 30 µL reaction contained 15 µL of 2X Platinum SYBR 
Green qPCR SuperMix-UDG with ROX kit (Invitrogen, Life 
Technologies, UK), 0.6 µL of each 10 µM primer, 6 µL of 
diluted cDNA (20 ng/µL reaction) and 7.8 µL nuclease-free 
H2O. Quantitative real-time PCR was carried out in a Bio-
Rad CFX96 Real-Time PCR Detection System (C1000™ 
Bio-Rad, UK) under the following thermal cycle: 2 min at 
50oC (UDG incubation), followed by 2 min at 95oC, 
followed by 40 cycles of 15 s at 95oC, then 15 s at 60oC 
followed by a melting curve. All samples were run in 
triplicates. qRT-PCR data were analyzed using the Bio-
Rad Sequence Detection System (Bio-Rad).  
 
The comparative CT method, 2-ΔΔCT (Livak and Schmittgen, 
2001) was used to determine average fold induction of 
messenger RNA (mRNA) by comparing the CT of the target 
gene to that of the reference gene. Reference gene 
expression was not altered by treatment. The amplified 
DNA or amplicon was evaluated by gel electrophoresis 
using MIDORIGREEN DNA stain (Anachem, UK). A 
GeneRuler 1kb Plus DNA Ladder (Thermo Scientific, UK) 
was run alongside PCR products in 1X Tris-acetate-EDTA 
buffer on agarose gel (2%) at 90 volts for 50 min using a 
Bio-Rad Gel electrophoresis system.  
 
 
Table 2.  Primers used and GenBank accession numbers for qRT-PCR in zebrafish 
Gene Accession no. Forward primer (5’-3’) Reverse primer (5’-3’) 
β-actin AF057040 ACATCCGTAAGGACCTG  GGTCGTTCGTTTGAATCTC 
SOD1 Y12236 CGCATGTTCCCAGACATCTA  GAGCGGAAGATTGAGGATTG 
SOD2 AW07696 CTAGCCCGCTGACATTACATC  TTGCCCACATAGAAATGCAC 




Samples were filtered through 0.2 µm cellulose filter prior 
to analysis. Liquid chromatography mass spectrometry 
(LC-MS/MS) was used to determine the actual 
concentrations of the pharmaceuticals. The mass 
spectrometer used for the analysis was a Thermo 
Scientific Q-Exactive Orbitrap mass spectrometer (Thermo 
Scientific, Hemel Hempstead, England) equipped with an 
Atlantis dC18 chromatography column operating in 
positive ion mode. For each sample, 10 µl was injected 
using an auto-sampler. The mobile phase was 10 mmol 
ammonium formate (adjusted to pH = 3.5 by formic acid), 
and acetonitrile. A gradient elution technique was used 
and the flow rate was 0.3 mL min-1. 
 
All detections were performed by mass spectrometry, in 
which the m/z transition for the drugs were as follows: 
261→153.9 for IFS, 261→139.9 for CYC, 254→155.9 for 
SUF, 734.47→158.1 for ERY, 366→349 for AMX, and 
235→86.3 for LDC and concentrations determined using a 
12-point calibration curve prepared using standard 
solutions. 
 
Validity criteria and statistical analysis 
 
Egg batches were only used if fertilization rates were ≥ 
70%. An assay was considered valid if the controls showed 
< 10% sublethal categorical and/or lethal effects at 120 hpf 
(OECD, 2006). The lethal concentrations were calculated 
using probit analysis. For other responses, independent 
sample t test and/or analysis of variance (one-way 
ANOVA) was performed after testing for normality and 
homogeneity of variance in treatment groups using 
Shapiro Wilk (p < 0.05) and Levene’s test (p < 0.05) 
respectively. Post-hoc, Dunnett test or Games-Howell test 
(SPSS® v22) was used to assess the significant 
differences among the test groups with p < 0.05 as the 





The 24 hpf embryos that were exposed to E3 medium only 
(controls) underwent normal development and all the 
control groups fulfilled the acceptance criteria of < 10% 
affected larvae at 120 hpf. The measured concentrations 
of the pharmaceuticals in this study were within 85 to 116% 
of the nominal concentrations and as a result, the nominal 
values were taken as effect concentrations and used in the 




With all the pharmaceuticals examined no significant 
mortality to the zebrafish embryos was recorded below 
100 mg/L. The calculation of LC50 and LC10 values was 
only possible for LDC and CYC with a 96 h LC50 of 0.71 
mM and 2.16 mM and a 96 h LC10 of 0.62 mM and 1.51 
mM respectively. 
 
LDC was the most toxic compound in this study with the 
highest concentrations (0.77-0.89 mM) causing mortality 
(p < 0.01) in 50-90% of the embryos after 24 h (Fig. 1a). 
Whereas, mortality was not observed in the embryos 
exposed to the highest CYC concentrations (3.44-4.59 
mM) until after 72 h with 30-80% of embryos affected (Fig. 
1b). For the remaining pharmaceuticals, < 10% of the 
larvae (p > 0.05) demonstrated mortality after 96 h. 
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Figure 1. Survival rate of 24 hpf zebrafish embryos exposed to (a) lidocaine, and (b) cyclophosphamide for 96 h. **p < 




Some important developmental defects such as pericardial 
edema, edema of the yolk sac, bent spine or scoliosis, and 
malformed tail or tail tip, were induced by the 
pharmaceuticals. Fig. 2 shows some of the noticeable 
abnormalities at different stages of zebrafish development 




Exposure to LDC enhanced hatching of the embryos. At 
48 h, only 35% of the embryos hatched in the control group 
but in the LDC treatments from 0.11 mM to 0.51 mM 
(sublethal concentrations) more than 70% of the alive 
embryos had hatched (p < 0.01) (Fig. 3a). In addition, 
55.5% of the alive embryos hatched in the 0.64 mM 
treatment at 48 h, although this was not significantly 
different to the control group. Associated with the rapid 
hatching in the sublethal treatments (0.25-0.51 mM), 
significant behavioural and developmental effects were 
observed (p < 0.05) (Fig. 4a and 5a) whereas the control 
embryos presented a normal development. However, 
hatching was delayed at higher concentrations of the 
anaesthetic with 33.4% and 70.8% of the alive embryos 
unhatched at 0.64 and 0.77 mM (p < 0.01) respectively by 
72 h (Fig. 3a). 
 
The most frequent effects (p < 0.05) to LDC exposure were 
side-laying of larvae due to lethargy, tail malformation, 
scoliosis and severe bradycardia (Fig. 2f, 2g, 4a and 5a). 
At 96 h, 30-95% of the larvae were side-laying and not 
actively swimming (even when prodded) in the 0.25 to 0.64 
mM treatments (p < 0.05) whereas all the zebrafish larvae 
were actively swimming in the 0.11 mM treatment. 
Significantly marked decreases (p < 0.01) in the zebrafish 
embryonic heart rate were also noted in 48 hpf to 120 hpf 
embryos exposed to 0.38 mM (88 beats/min), 0.51 mM (72 
beats/min), or 0.64 mM (58 beats/min) of LDC indicating 
bradycardia (Fig. 5a). A significant occurrence of 
neurotoxicity (p < 0.05) as evidenced by scoliosis or 
curved body and tail deformation was observed after 96 h 
in 22.2% of the alive embryos exposed to 0.64 mM (Fig. 
4a). Pericardial edema was also significantly induced in 





The lethal concentrations of CYC (2.1-4.59 mM) adversely 
affected hatchability in exposed zebrafish embryos (p < 
0.001). The overall hatchability of the embryos declined as 
the exposure concentration increased.  At 48 h of 
exposure, more than 90% of embryos had hatched in the 
control, and 0.76-1.34 mM treatments; 50% in 2.1 mM; 
while only 20 and 15% of embryos hatched in the 3.44-
4.59 mM treatments respectively (Fig. 3b). At 72 h, when 
non-hatchability was < 10% in control, and 0.76-1.34 mM 
treatments, 42.2% of alive zebrafish embryos were 
unhatched at 2.1 mM; 64.6% unhatched at 3.44 mM and 
none hatched at 4.59 mM. At 96 h, 45% of the larvae were 
still unable to hatch in the 2.1 mM treatment. The non-
hatched embryos from 3.44-4.59 mM treatment presented 
a rigid chorion at 72 h but died without being able to hatch 
after 96 h of exposure.  
 
The most common abnormalities (p < 0.05) caused by 
CYC exposure were observed at the lethal concentrations 
and include edema of the pericardium, malformed tail and 
curved spine. Bradycardia was also induced in the 
embryos following CYC exposure (Fig. 5b). At 48 h, when 
there was no mortality in the treatment groups, 30 and 60%  
a b 
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of embryos had pericardial edema in the 3.44, and 4.59 
mM treatments respectively (data not shown). Neurotoxic 
effects, tail malformation and bent spine, were also 
significantly induced (p < 0.05) at 3.44 and 4.59 mM 
respectively (Fig. 2h) at 48 h in 20% of the embryos (data 
not shown). At 72 h, 15.5% of the alive embryos had 
pericardial edema at 2.1 mM; 43.7% had edema in 3.44 
mM and all the non-hatched alive embryos at 4.59 mM 
(data not shown). After 96 h, pericardial edema and yolk 
edema were found respectively in 26.7% (p < 0.05) and 
18.3% (p < 0.001) of the alive embryos exposed to 2.1 mM 
(Fig. 4b). Sublethal levels of the anticancer drug (0.76-1.34 
mM) did not induce any significant abnormalities in the 
embryos and the adverse effects (p < 0.05) were only seen 
in form of lethargy in 26.1% of the larvae exposed to 1.34 
mM after 96 h (Fig. 4b). Side-laying of the fish increased 
with concentration with 45% of alive larvae exposed to 2.1 
mM inactive after the exposure period.   
 
At 48 and 72 h when mortality was < 10% in the 2.1 mM 
treatment, about 10-15.5% of the embryos had their heads 
stuck in a rigid and opaque chorion (Fig. 2j) and were 
unable to free themselves with 18.3% of the alive larvae 
significantly affected (p < 0.05) by 96 h. (Fig. 4b). This 
partial dechorionation was only noted in the CYC exposure 
and was also seen in the embryos exposed to the higher 
concentrations, although occurrence was insignificant. 
Significant differences (p < 0.05) between the treatments 
and the control group, in terms of the heart rate, were only 
noted (from 48 to 96 h) when the embryos were exposed 




Exposure of the embryos to IFS had no effects on hatching 
with more than 80% of D. rerio embryos hatched at 48 h or 
72 hpf, and hatchability was 100% by 96 h at all tested 
concentrations (Fig. 3c). IFS had little or negligible effects 
on the development of the 24 hpf embryos at the tested 
concentrations; less than 10% of the embryos had 
pericardial edema. However, noticeable behavioural 
changes (p < 0.05) with regards to the side-laying of the 
larvae were observed in the treatments, 0.76-2.3 mM after 
96 h (Fig. 4c). The heart rates of the larvae were not 
significantly affected (p > 0.05) by IFS exposure with the 
average heartbeats ranging between 150 and 170 




In sulfamethoxazole exposure, hatching was found to be 
enhanced at 48 h (p < 0.05), increasing with the 
concentration of the antibiotic except for the 0.79 mM 
treatment (Fig. 3d). While 25% and 35% of embryos were 
hatched in the control and lowest tested concentration 
(0.09 mM) respectively by 48 h, 85% of embryos were 
observed to have hatched in the highest treatment group 
(1.58 mM). However, this latter treatment induced the 
highest occurrence of abnormalities (p < 0.01): pericardial 
edema (30%), yolk sac edema (30%), curved body (30%), 
and side-laying (60%) in the exposed larvae after 96 h (Fig. 
4d). A significant decrease (p < 0.05) in heart rate of 
zebrafish was also noticed at the highest concentration 
after 96 h (Fig. 5d). The lower concentrations of the 
sulfonamide had little or no effects (p > 0.05) on the 
development of the embryos (< 10% malformed embryos) 
(Fig. 4d), and significant effects (p < 0.05) on embryonic 





Although, hatching of zebrafish embryos was enhanced (p 
< 0.01) at the higher concentrations of erythromycin 
(0.068-0.136 mM) at 48 h, over 90% of the embryos 
exposed to ERY at all tested concentrations and in the 
control, had hatched by 72 h (Fig. 3e). Moreover, the 
macrolide did not cause any malformation nor induced any 
behavioural response in the embryos throughout the 
duration of exposure. ERY, however, significantly 
decrease (p < 0.05) the heart rate of the embryos in all 
treatments at 24 h and in the highest treatment at 48 h 
while no significant effects on the heart rate were seen in 




AMX had no effects on the hatching of zebrafish embryos 
with 100% hatchability observed in all the treatments and 
control by 48 h (Fig. 3f). Likewise, no abnormalities and 
behavioural effects were induced by AMX. Significant 
differences (p < 0.05) in the heart rate of embryos between 
the control and treatments (1.09-2.73 mM) were only 
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Figure 2. Phenotypic changes in zebrafish embryos following pharmaceutical exposure: (a) unhatched 48 hpf control 
embryo; (b) hatched 72 hpf control larva with normal notochord or spine; (c) 96 hpf control; (d) unhatched 48 hpf embryo 
at 3.44 mM cyclophosphamide; (e) 48 hpf larva at 0.51 mM lidocaine; (f & g) 72 hpf larvae at 0.64 mM lidocaine; (h) 72 
hpf larvae at 3.44 mM cyclophosphamide; (i) unhatched 96 hpf and (j) hatched 96 hpf larva at 2.1 mM cyclophosphamide; 
(k) 96 hpf larva at 1.58 mM sulfamethoxazole; (l) 96 hpf larva at 0.77 mM lidocaine.  Abbreviations: n, notochord; p, 
pericardium; t, tail; ys, yolk sac; bs, bent spine (scoliosis); tm, tail malformation; pe, pericardial edema; yse, yolk sac 
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Figure 3. Hatching rate in 24 hpf embryos exposed to (a) lidocaine; (b) cyclophosphamide; (c) ifosfamide; (d) 
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Figure 4. Frequency (%) of zebrafish embryos affected by sublethal endpoints after 96 h exposure to lidocaine (a); 
cyclophosphamide (b); ifosfamide (c); and sulfamethoxazole (d). (pe) pericardial edema; (sl) side-laying; (cb) curved body; 
(hc) head stuck in chorion; and (td) tail deformation. *p < 0.05, **p < 0.01, ***p < 0.001. Error bar represents SE. 
a b 
c d 
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Figure 5. Effects of lidocaine (a); cyclophosphamide (b); ifosfamide (c); sulfamethoxazole (d); erythromycin (e); and 
amoxicillin (f) on heart rate in zebrafish embryos (ap < 0.05; bp < 0.01; cp < 0.001). Error bar represents SD 
 
CAT enzyme activity 
 
In the zebrafish embryos exposed to LDC, CAT activity was significantly inhibited at 96 h in the 0.64 mM treatment but a 
significant increase in CAT activity was noticeable at the sublethal concentrations, 0.25-0.51 mM (Fig. 6a). Likewise, CAT 
activity was significantly increased in the 120 hpf larvae in IFS exposure but at the highest sublethal concentration (Fig. 
6c). However, no significant changes in CAT activity were observed at 96 h in the larvae exposed to the sublethal levels 
of CYC and ERY (Fig. 6b and 6d). Unfortunately, due to loss of materials no results could be presented for CAT activity 
in the larvae exposed to SUF and AMX. 
  
d e f 
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Figure 6. CAT activity in zebrafish embryos after 96 h exposure to lidocaine (a); cyclophosphamide (b); ifosfamide (c); 
and erythromycin (d). *p < 0.05, **p < 0.01. Error bar represents SE 
 
mRNA expression levels of antioxidant enzymes 
 
Based on qPCR measurements, the oxidative stress 
related genes were significantly regulated in the zebrafish 
embryos after exposure to the test pharmaceuticals. Table 
3 shows the fold change or relative mRNA expression 
levels of the antioxidant enzymes. CAT, SOD1 and SOD2 
genes were significantly upregulated (p < 0.05) in the 
embryos exposed to 0.25-0.51 mM LDC, and significantly 
downregulated (p < 0.01) at the 0.64 mM of LDC.  
Likewise, an upregulation of CAT and SOD1 genes was 
induced in the embryos as a result of CYC exposure while 
the expression of SOD2 gene was significantly increased 
only at 1.34 mM of CYC. A significant upregulation of the 
CAT gene was also noticed in embryos exposed to 2.3 mM 
and 1.58 mM of IFS and SUF respectively. However, the 
expression of SOD1 was unaffected in the embryos 
exposed to both pharmaceuticals. SOD2 gene expression 
significantly increased at 2.3 mM of IFS compared to the 
control group, and a significant decrease in the 
expressions of the gene was observed at 0.31 mM and 
0.09 mM of IFS and SUF respectively. 
Significant increases (p < 0.05) in CAT and SOD1 gene 
expressions were induced in the larvae at 0.272 mM of 
ERY while SOD2 gene was significantly downregulated in 
the zebrafish following the antibiotic exposure. The 
antioxidant enzymes gene expression levels of CAT, 
SOD1 and SOD2 were all significantly downregulated (p < 









Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Rerio) Following Embryonic Exposure to Human Pharmaceuticals 
Aderemi et al.            120 
 
Table 3. The average fold change in mRNA expression levels of the antioxidant enzymes using qRT-PCR 
 Concentration (mM) CAT SOD1 SOD2 
Lidocaine 
Control  1.00 ± 0.01a 1.03 ± 0.03 0.95 ± 0.02 
0.25  2.17 ± 0.10*** 1.05 ± 0.01 1.19 ± 0.08 
0.38  2.63 ± 0.07*** 2.28 ± 0.03*** 2.41 ± 0.25* 
0.51  2.79 ± 0.09*** 2.12 ± 0.02*** 3.75 ± 0.08** 
0.64  0.49 ± 0.03** 0.48 ± 0.03** 0.41 ± 0.02*** 
Cyclophosphamide 
Control  0.99 ± 0.06 1.08 ± 0.04 0.98 ± 0.01 
0.76  1.66 ± 0.01* 1.38 ± 0.04 1.17 ± 0.05 
1.34  3.75 ± 0.09*** 3.95 ± 0.10*** 3.29 ± 0.10*** 
2.10  3.36 ± 0.12** 7.22 ± 0.28*** 1.14 ± 0.04 
Ifosfamide 
Control  4.12 ± 2.18 1.12 ± 0.08 1.12 ± 0.06 
0.31  8.20 ± 0.34 0.72 ± 0.02 0.43 ± 0.01*** 
2.30  18.98 ± 2.00** 1.49 ± 0.14 2.59 ± 0.06*** 
Sulfamethoxazole  
Control  1.33 ± 0.27 1.01 ± 0.04 1.07 ± 0.04 
0.09  1.38 ± 0.09 1.02 ± 0.08 0.77 ± 0.01** 
1.58  2.27 ± 0.07* 1.08 ± 0.12 0.97 ± 0.02 
Erythromycin 
Control   1.33 ± 0.27 1.01 ± 0.04 1.07 ± 0.04 
0.017 1.89 ± 0.07 1.00 ± 0.04 0.64 ± 0.03*** 
0.272  2.65 ± 0.03* 1.27 ± 0.07* 0.74 ± 0.01** 
Amoxicillin 
Control  1.01 ± 0.02 1.03 ± 0.03 1.06 ± 0.04 
0.41  0.17 ± 0.01*** 0.02 ± 0.00** 0.12 ± 0.00*** 
2.73  0.40 ± 0.01*** 0.40 ± 0.01** 0.49 ± 0.02*** 




Little is known regarding the risk posed by LDC toward 
aquatic species. According to a safety data report 
(AstraZeneca, 2016) a 96 h LC50 of 0.45 mM has been 
reported for the anaesthetic in adult zebrafish which is very 
close to the value obtained for the 24 h embryos in this 
study. Interestingly, the significant occurrence of 
neurotoxicity and cardiovascular effects in the fish 
embryos at lethal and sublethal levels of LDC correlates 
with its adverse effects in mammals (Drasner et al., 1994; 
Kovacic and Somanathan, 2011). The enhancement of 
embryo hatching, and its delay caused by LDC exposure 
may be attributed to different toxic mechanisms. 
Yamagami (1981) suggested that such alterations in 
hatching could arise due to the induction of abnormal 
functioning of the enzyme chorionase and the inability of 
the emerging larva to break the eggshell. 
 
The median lethal concentration of 8.4 mM reported for 
CYC in 2.5 hpf embryos exposed for 72 h (Weigt et al., 
2011) is much higher than the 72 h LC50 (3.75 mM) 
obtained for CYC in this study. The difference may be 
attributed to the presence of chorion at early stages which 
shield the early embryos from teratogen actions (Ali et al., 
2011). The abnormalities induced in 20-60% of 48-72 hpf 
embryos at the highest CYC treatment, in agreement with 
Weigt et al. (2011), demonstrate the ability of zebrafish 
embryos to activate proteratogenic compounds without 
any addition of an exogenous metabolic activation system. 
Zhu et al. (2014) reported a significant occurrence of 
cardiotoxic manifestations in 48 hpf zebrafish embryos 
exposed to CYC for 24 h which is in consonance with 
findings obtained at 72 hpf in this study. Pericardial edema 
or effusion induced by CYC has also been reported in 
humans (Katayama et al., 2009; Nakamura et al., 2010).  
 
The head stuck in chorion phenomenon noticed in a 
significant number of embryos at the highest CYC levels 
was earlier reported in pikeperch eggs exposed to tannic 
acid and was attributed to possible inhibition of chorionase 
activity by the test compound (Demska-Zakes et al., 2005). 
In the aquatic environment, few studies have reported the 
effects of antimicrobials including SUF, AMX and ERY in 
D. rerio embryos probably as a result of the low toxicity 
shown generally by antibiotics to fish (Oliveira et al., 2013). 
The enhancement of hatching by SUF and ERY in this 
study may be due to the induction of abnormal functioning 
of chorionase activity (Yamagami, 1981). However, a 
delay in hatching was reported in 5 hpf embryos exposed 
to 0.1-100 µg/L SUF (Liu et al., 2020). The increase in the 
defects especially pericardia edema observed in 30% of 
embryos exposed to SUF from 72-96 h may be due to the 
absence of the chorion to offer the embryos protection to 
some extent by acting as a barrier to certain chemicals 
(Braunbeck et al., 2005). Lin et al. (2013) reported a similar 
occurrence in juvenile zebrafish (10-13.33%) after 1-2 hpf 
embryos were exposed to 3.95 µM of SUF for 96 h.  
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However, the higher toxicity shown by SUF toward the 
early life stages of the fish in the earlier study, suggests 
that the chorion is unlikely to have much effect on their 
diffusion.  
 
Zebrafish has been identified as an alternative model for 
investigating congenital hypothyroidism (Porazzi et al., 
2009). The curvature of the body defect in the zebrafish 
exposed to SUF in this study suggests that the drug may 
affect the development of the nervous system. This is in 
consonance with an earlier study that reported tail bending 
deformity in zebrafish embryos exposed to sulfonamides 
attributing it to hypothyroidism (Lin et al., 2013). Thyroxine 
is involved in regulating neural signalling in zebrafish early 
embryonic stages, promoting the development of the 
nervous system (Yonkers and Ribera, 2008). Bradycardia 
and pericardial effusion have been listed as some of the 
cardiovascular signs or symptoms of hypothyroidism in 
humans (Khaleeli et al., 1982; Levey and Klein, 1994).  
The cardiovascular effects of SUF in this study, although 
not fully understood, may also be linked to hypothyroidism 
and further studies need be carried out to ascertain this.  
 
Oxidative stress is a deleterious process caused by an 
imbalance between oxidants and antioxidants in steady 
state resulting in damage to cellular components including 
proteins, lipids and DNA (Doi et al., 2011). Sources of 
oxidants or reactive oxygen species, O2- and H2O2, are 
functionally and spatially related to the production and 
cellular localization of natural antioxidant enzymes such as 
SOD and CAT (Gobe and Crane, 2010). SODs detoxify O2- 
into H2O2. H2O2 is then converted to water and molecular 
O2 by CAT. The balance between ROS production and 
antioxidant system leads to regulated intracellular steady 
state levels of ROS in aerobic organisms (Sies, 1997). 
 
A significant upregulation of the gene expressions of 
SOD1, SOD2 and CAT and the consistency between the 
mRNA expression levels of CAT and its enzyme activity, 
at sublethal levels of LDC (0.25-0.51 mM), suggest that 
these antioxidants may play an important role in 
preventing LDC-induced neurotoxicity as side-laying and 
bradycardia were the only significant phenotypic effects 
elicited in the larvae. The absence of malformed heart and 
the neurotoxicity suppression (occurring in ≤ 10% of 
larvae) against possible ROS attack is possibly via O2- 
dismutation and H2O2 scavenging.  
 
Furthermore, this study demonstrated a significant 
decrease in the amounts of transcripts of antioxidant 
enzymes SOD1, SOD2, and CAT as well as a 
corresponding decrease in CAT activity in embryos 
exposed to the higher LDC concentration (0.64 mM) at 96 
h post treatment. This indicates that, the generation rate of 
ROS was much higher than the clearing capacity of the 
antioxidant systems, causing oxidative stress and possibly 
was responsible for the mortality, cardiovascular toxicity 
and neurotoxicity observed in the fish after 96 h of 
exposure.   
Recent studies have shown that mitochondria are the main 
source of ROS and the major target of ROS-induced 
damage (Ravikumar et al., 2010). Mitochondria have been 
known to be the most important cellular source of O2- and 
H2O2 in aerobic organisms (Okamoto et al., 2016). The 
toxicity of LDC in humans has been associated with ROS 
induction (Kovacic and Somanathan, 2011). LDC 
penetration of the mitochondria has been identified with 
the outcome of significant inhibition of mitochondrial 
function, alteration of gene expression, induction of ROS 
and eventual apoptosis in cells (Kovacic and Somanathan, 
2011; Lee et al., 2016). A strong evidence for neurotoxicity 
of local anaesthetics, such as LDC and bupivacaine, 
through apoptosis triggered by ROS production has been 
reported (Park et al., 2005). Since dysfunctional 
mitochondria are central to the formation of excess ROS 
and are known key intracellular targets for LDC (Okamoto 
et al., 2016), it is possible that the downregulation of 
SOD2, a mitochondrial SOD, at 0.64 mM LDC in this study, 
had a major part to play in the cardiotoxic and neurotoxic 
abnormalities seen in the zebrafish larvae via disruption of 
the mitochondrial antioxidant system.  
 
The cellular mechanism of toxicity or cardiotoxicity of 
anticancer agents, CYC and IFS, in animal models is 
linked with the production of high levels of ROS by their 
metabolites, culminating in oxidative stress (Nepomuceno, 
2011; Lamberti et al., 2014). The substantial upregulation 
of CAT and most especially SOD1 gene expressions at 2.1 
mM of CYC indicates very high levels of ROS which the 
antioxidant systems are unlikely unable to cope with, 
possibly resulting in the CYC-induced mortality and 
teratogenic effects (hatching failure, yolk sac edema and 
cardiotoxic manifestations) seen in the larva at 96 h post 
treatment.  
 
CYC, at sublethal and non-toxic (at organism level) 
concentrations (0.76-1.34 mM) upregulated the mRNA 
expression levels of CAT, SOD1 and SOD2, an indication 
that these antioxidants may play a vital role in protecting 
the exposed embryos from the teratogenic effects of the 
anticancer drug. The induction of only CAT gene 
expression at the lowest CYC concentration suggests that 
CAT could be involved in a more critical role in the 
detoxification process than SOD1 and SOD2. The 
teratogenic risks posed by IFS exposure is likely to have 
been suppressed by the scavenging and dismutative 
actions of CAT and SOD2 respectively as shown by the 
significant upregulation of their gene expressions with the 
expression of CAT in concordance with an increase in its 
enzyme activity in the exposed larvae at the highest tested 
concentration of IFS.  
 
An upregulation of the transcriptional expression levels of 
SOD1 and CAT (at the highest ERY treatment) shows that 
the antioxidants may be involved in the prevention of ERY 
induced-embryotoxicity. In addition, the significant 
induction of CAT mRNA expression in the fish at the 
highest concentration of SUF cannot rule out the possibility  
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that the cardiotoxic and neurotoxic effects elicited in the 
fish could be due to ROS accumulation as the antioxidant 
response may not be enough to counteract the 
accumulated ROS. The significant downregulation of the 
antioxidant genes especially SOD2 at the non-toxic 
concentrations of IFS, SUF, ERY and AMX, although not 
clearly understood, correlates with the absence of 
embryotoxicity in the zebrafish.  
 
The induction of the mRNA expression levels of the 
antioxidants and CAT activity by the sublethal 
concentrations of LDC, CYC, IFS, and ERY in this study 
suggest that an oxidative stress response (at a higher level 
of biological organization) is possible in the zebrafish 
exposed for a longer period or to a higher concentration of 
the pharmaceuticals (Gunnarsson et al., 2009). However, 
the evaluation of a battery of biomarkers would be 





The multi-level effect approach adopted in this study 
provides a better understanding of the mechanisms of 
toxicity employed by the pharmaceuticals especially in 
LDC, CYC and SUF exposures and the evaluation of more 
nonspecific or specific biomarkers would have provided 
more details on the pathways. The sublethal 
concentrations of LDC, CYC, IFS and ERY activated 
protective antioxidant defenses in the embryos in this 
study. Although, these concentrations are above the levels 
measured in the aquatic environment, their significant 
upregulation of the antioxidants at the transcriptomic and 
cellular levels in this study suggest possible phenotypic or 
oxidative stress response in the fish after a chronic 
exposure to the pharmaceuticals. This study shows the 
essence of evaluating stress biomarkers and emphasizes 
the need for chronic studies in order to have a more 
meaningful assessment of pharmaceutical effects on 





This work was partly funded by the EU Transnational 
Territorial Cooperation programme INTERREG IVB NWE 
projects (PILLS project 008B & “noPILLS in our waters”) 
and a PhD studentship from Glasgow Caledonian 
University received by Adeolu Aderemi.  The project was 
also supported by the Rostrees Trust (M160, M160-F1, 
M160-F2), National Eye Research Centre (SCIAD063) 






Aebi, H. (1984). Catalase in vitro. Methods in Enzymology 
105: pp.121-126. 
Albalawi, A., Alhasani, R.H.A., Biswas, L., Reilly, J., 
Akhtar, S., Shu, X. (2018). Carnosic acid attenuates 
acrylamide-induced retinal toxicity in zebrafish 
embryos. Experimental Eye Research, 175: pp.103-
114 
Ali, S., Champagne, D.L., Spaink, H.P., et al. (2011). 
Zebrafish embryos and larvae: a new generation of 
disease models and drug screens. Birth Defects 
Research Part C Embryo Today 93(2): pp.115-133. 
AshaRani, P., Wu, Y., Gong, Z., Valiyaveettil, S. (2008). 
Toxicity of silver nanoparticles in zebrafish models. 
Nanotechnology 19, 255102 (8pp), doi:10.1088/0957-
4484/19/25/255102 
AstraZeneca (2016). Safety data sheet- xylocaine solution 
for oral pump spray. Retrieved from 
https://www.astrazeneca.com.au/content/dam/az-
au/Material%20Safety%20Data/Xylocaineltsupgt174lts
upgt-Oral-Pump-Spray.pdf on 1st May 2017 
Bartoskova, M., Dobsikova, R., Stancova, V., Pana, O., 
Zivna, D., Plhalova, L., Blahova, J., Marsalek, P. 
(2014). Norfloxacin – Toxicity for zebrafish (Danio rerio) 
focused on oxidative stress parameters. BioMed 
Research International, 
http://dx.doi.org/10.1155/2014/560235. 
Bradford, M.M. (1976). A rapid and sensitive method for 
the quantitation of microgram quantity of protein 
utilizing the principle of protein-dye binding. Analytical 
Biochemistry 72: pp.248-254. 
Braunbeck, T., Boettcher, M., Hollert, H et al. (2005). 
Towards an alternative for the acute fish LC50 test in 
chemical assessment: the fish embryo toxicity test goes 
multispecies- an update. ALTEX 22: 87-102. 
Carlsson, G., Patring, J., Kreuger, J., Norrgren, L., 
Oskarsson, A. (2013). Toxicity of 15 veterinary 
pharmaceuticals in zebrafish (Danio rerio) embryos. 
Aquatic Toxicology 126: pp.30-41. 
Cassar, S., Adatto, I., Freeman, J.L., et al. (2020). Use of 
Zebrafish in Drug Discovery Toxicology. Chemical 
Research in Toxicology, 33: pp.95-118 
Comber, S., Gardner, M., Sorme, P., Leverett, D., Ellor, B. 
(2018). Active pharmaceutical ingredients entering the 
aquatic environment from wastewater treatment works: 
A cause for concern? Science of the Total Environment 
613-614: pp.538-547. 
Connon, R.E., Geist, J., Werner, I. (2012). Effect-based 
tools for monitoring and predicting the ecotoxicological 
effects of chemicals in the aquatic environment: 
Review, Sensors 12: pp.12741-12771. 
David, A., Pancharatna, K. (2009). Developmental 
anomalies induced by a non-selective COX inhibitor 
(ibuprofen) in zebrafish (Danio rerio). Environmental 
Toxicology and Pharmacology 27: pp.390-395. 
Demska-Zakes, K., Zakes, Z., Roszuk, J. (2005). The use 
of tannic acid to remove adhesiveness from pikeperch, 
Sander lucioperca, eggs. Aquaculture Research 36: 
pp.1458-1464. 
Diniz, M.S, Salgado, R., Pereira, V.J., Carvalho, G., 
Oehmen, A., Reis, M.E.M., Noronha, J.P. (2015). 
Ecotoxicity of ketoprofen, diclofenac, atenolol, and their 
photolysis byproducts in zebrafish (Danio rerio). 
Science of the Total Environment 505: pp.282-289. 
Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Rerio) Following Embryonic Exposure to Human Pharmaceuticals 
Int. J. Toxicol. Environ. Health        123 
 
 
Doi, T., Puri, P., Bannigan, J. (2011). Pre-treatment with 
N-acetylcysteine upregulates superoxide dismutase 2 
and catalase genes in cadmium-induced oxidative 
stress in the chick omphalocele model. Pediatric 
Surgery International 27: pp.131-136. 
Drasner, K., Sakura, S., Chan, V.W.S., Bollen, A.W., 
Ciriales, R. (1994). Persistent sacral sensory deficit 
induced by intrathecal local anesthetic infusion in the 
rat. Anesthesiology 80: 847-852. 
Fernández-López, C., Guillén-Navarro, J.M., Padilla, J.J., 
Parsons, J.R. (2016). Comparison of the removal 
efficiencies of selected pharmaceuticals in wastewater 
treatment plants in the region of Murcia, Spain. 
Ecological Engineering 95: pp.811–816. 
Ferreira Nuno, G.C., Morgado, R., Santos Miguel, J.G., 
Soares Amadeu, M.V.M., Loureiro, S. (2015). 
Biomarkers and energy reserves in the isopod 
Porcellionides pruinosus: The effects of long-term 
exposure to dimethoate. Science of the Total 
Environment 502: pp.91-102. 
Fu, J., Gong, Z., Kelly, B.C. (2019). Metabolomic profiling 
of zebrafish (Danio rerio) embryos exposed to the 
antibacterial agent triclosan, Environmental Toxicology 
and Chemistry, 38: pp.240-249. 
Gobe, G., Crane, D. (2010). Mitochondria, reactive oxygen 
species and cadmium toxicity in the kidney. Toxicology 
Letter 15(198): pp.49-55. 
Gonzalez-Pleiter, M., Gonzalo, S., Rodea-Palomares, I., 
Leganes, F., Rosal, R., Boltes, K., Marco, E., 
Fernandez-Pinas, F. (2013). Toxicity of five antibiotics 
and their mixtures towards photosynthetic aquatic 
organisms: implications for environmental risk 
assessment. Water Research 47: pp.2050-2064. 
Gunnarsson, L., Kristiansson, E., Rutgersson, C., Sturve, 
J., Fick, J., Forlin, L., Larsson Joakim, D.G. (2009). 
Pharmaceutical industry effluent diluted 1:500 affects 
global gene expression, cytochrome P450 1a activity, 
and plasma phosphate in fish. Environmental 
Toxicology and Chemistry 28(12): pp.2639-2647. 
Helwig, K., Hunter, C., MacLachlan, J. et al. (2013). 
Micropollutant point sources in the built environment: 
identification and monitoring of priority pharmaceutical 
substances in hospital effluents. Journal of 
Environmental and Analytical Toxicology 3: 177. doi: 
10.4172/2161 – 0525.1000177. 
Huggett, R.J., Kimerly, R.A., Mehrle, P.M., Jr. Bergman, 
H.L. (1992). Biomarkers: Biochemical, Physiological 
and Histological Markers of Anthropogenic Stress; 
Lewis Publishers: Chelsea, MI, USA. 
Katayama, M., Imai, Y., Hashimoto, H., Kurata, M., Nagai, 
K., Tamita, K., Morioka, S., Frukawa, Y. (2009). 
Fulminant fata cardiotoxicity following 
cyclophosphamide therapy. Journal of 
Cardiotoxicology 54: pp.330-334. 
Khaleeli, A.A., Memon, N. (1982). Factors affecting 
resolution of pericardial effusions in primary 
hypothyroidism: a clinical Postgraduate Medical 
Journal 58: pp.473–476. 
Klein, I., Danzi, S. (2007). Thyroid Disease and the Heart. 
Circulation 116: pp.1725-1735. 
Kostich, M.S., Batt, A.L., Lazorchak, J.M. (2014). 
Concentrations of prioritized pharmaceuticals in 
effluents from 50 large wastewater treatment plants in 
the US and implications for risk estimation. 
Environmental Pollution 184: pp.354–359. 
Kovacic, P., Somanathan, R. (2011). Mechanism of 
anesthetic toxicity: Metabolism, reactive oxygen 
species, oxidative stress, and electron transfer; 
Review, International Scholarly Research Network 
Anesthesiology, 10pp. doi:10.5402/2011/402906. 
Lamberti, M., Giovane, G., Garzillo, E.M., Avino, F., Feola, 
A., Porto, S., Tombolini, V., Di Domenico, M. (2014). 
Animal models in studies of cardiotoxicity side effects 
from antiblastic drugs in patients and occupational 
exposed workers. BioMed Research International 8pp, 
http://dx.doi.org/10.1155/2014/240642. 
Lee, Y.J., Kim, S.A., Lee, S.H. (2016). Hyaluronan 
suppresses lidocaine-induced apoptosis of human 
chondrocytes in vitro by inhibiting the p53-dependent 
mitochondrial apoptotic pathway. Acta Pharmacologica 
Sinica 37: pp.664-673. 
Levey, G.S., Klein, I. (1994). Disorders of the thyroid. In: 
Stein’s Textbook of Medicine, 2nd ed. Boston, Mass; 
Little Brown & Co.: 1994; 1383. 
Lin, T., Chen, Y., Chen, W. (2013). Impact of toxicological 
properties of sulfonamides on the growth of zebrafish 
embryos in the water. Environmental Toxicology and 
Pharmacology 36: pp.1068-1076. 
Liu, J., Wei, T., Wu, X., Zhong, H., Qiu, W., Zheng, Y. 
(2020). Early exposure to environmental levels of 
sulfamethoxazole triggers immune and inflammatory 
response of healthy zebrafish larvae. Science of the 
Total Environment, 703: 134724. 
Livak, K., Schmittgen, T. (2001). Analysis of Relative gene 
expression data using Real-Time Quantitative PCR and 
the 2-ΔΔCT method. Methods 25(4): pp.402-408. 
Lemos, Marco F. L., Soares, Amadeu M. V. M., Correia, 
António, C., Esteves, Ana C. (2010). "Proteins in 
ecotoxicology - How, why and why 
not?" PROTEOMICS 10 (4): pp.873-887. 
Magdaleno, A., Saenz, M.E., Juarez, A.B., Moretton, J. 
(2015). Effects of six antibiotics and their binary 
mixtures on growth of Pseudokirchneriella subcapitata. 
Ecotoxicology and Environmental Safety 113: pp.72-
78. 
Mao, L., Jia, W., Zhang, L., Zhang, Y., Zhu, L., Sial, M.U., 
Jiang, H. (2020). Embryonic development and oxidative 
stress effects in the larvae and adult fish livers of 
zebrafish (Danio rerio) exposed to the strobilurin 
fungicides, kresoxim-methyl and pyraclostrobin. 
Science of the Total Environment, 729: 139031, 
https://doi.org/10.1016/j.scitotenv.2020.139031 
Mesquita, B. et al., 2017. Gold Nanorods Induce Early 
Embryonic Developmental Delay and Lethality in 
Zebrafish (Danio Rerio), Journal of Toxicology and 
Environmental Health A, 80 (13-15): pp. 672-687. 
 
Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Rerio) Following Embryonic Exposure to Human Pharmaceuticals 
Aderemi et al.            124 
 
 
Nakamura, S., Aoki, M., Mori, A., Nakahara, T., Sakamoto, 
K., Ishii, K. (2010). Analysis of cardiac toxicity caused 
by cyclophosphamide in the H9c2 cell line and isolated 
and perfused rat hearts. Gan To Kagaku Ryoho 37: 
pp.677-680. 
Nepomuceno, J.C. (2011). Antioxidants in Cancer 
Treatment, Current Cancer Treatment - Novel Beyond 
Conventional Approaches, Prof. Oner Ozdemir (Ed.), 





Nowakowska, B. et al. (2020). Acute exposure of zebrafish 
(Danio rerio) larvae to environmental concentrations of 
selected antidepressants: Bioaccumulation, 
physiological and histological changes. Comparative 
Biochemistry and Physiology Part C: Toxicology and 
Pharmacology, 229: 108670. 
OECD (2006). Test No. 236: Fish embryo acute toxicity 
(FET) test. OECD Guidelines for the Testing of 
Chemicals. Paris. 
Okamoto, A., Tanaka, M., Sumi, C., et al. (2016). The 
antioxidant N-acetyl cysteine suppresses lidocaine-
induced intracellular reactive oxygen species 
production and cell death in neuronal SH-SY5Y cells. 
BMC Anesthesiology 16: pp.104 doi:10.1186/s1287-
016-0273-3. 
Oliveira, R., McDonough, S., Ladewig, J.C.L., Soares, 
M.V.M, Nogueira, A.J.A., Domingues, I. (2013). Effects 
of oxytetracycline and amoxicillin on development and 
biomarkers activities of zebrafish (Danio rerio). 
Environmental Toxicology and Pharmacology 36: 
pp.903-912. 
Park, C.J., Park, S.A., Yoon, T.G., Lee, S.J., Yum, K.W., 
Kim, H.J. (2005). Bupivacaine Induces Apoptosis via 
ROS in the Schwann Cell Line. Journal of Dental 
Research, 84(9): pp.852-857. 
Patibandla, S., Zhang, Y., Tohari, A.M., Gu, P., Reilly, J., 
Chen, Yu., Shu, Xinhua. (2019). Comparative analysis 
of the toxicity of gold nanoparticles in zebrafish. Journal 
of Applied Toxicology, https://doi.org/10.1002/jat.3628 
Porazzi, P., Calebiro, D., Benato, F., Tiso, N., Persani, L. 
(2009). Thyroid gland development and function in the 
zebrafish model. Molecular and Cellular Endocrinology 
312: pp.14-23. 
Ravikumar, B., Sarkar, S., Davies, J.E., Futter, M., Garcia-
Arencibia, M., Green-Thompson, Z.W., et al. (2010). 
Regulation of mammalian autophagy in physiology and 
pathophysiology. Physiological Reviews 90: pp.1383-
1435. 
Sachett, A., Bevilaqua, F., Chitolina, R., Garbinato, C.L., 
Gasparetto, H., Magro, J.D., et al. (2018). Ractopamine 
hydrochloride induces behavioural alterations and 
oxidative status imbalance in zebrafish. Journal of 
Toxicology and Environmental Health Part A 81(7): 
pp.1-8. 
Short, C.R., Flory, W., Hsieh, L.C., Aranas, T., Barker, S.A. 
(1988). Metabolism and urinary elimination of lidocaine 
in horse. Proceedings of the 7th International 
Conference of Racing Analysts and veterinarian. pp.1-
7. 
Sies, H. (1997). Oxidative stress: oxidants and 
antioxidants. Experimental Physiology 82: pp.291-295. 
Timme-Laragy, A.R., Van Tiem, L.A., Linney, E.A., Di 
Giulio, R.T. (2009). Antioxidant responses and NRF2 in 
synergistic developmental toxicity of PAHs in zebrafish. 
Toxicological Sciences 109(2): pp.217-227. 
Van den Brandhof, E.J., Montforts, M. (2010). Fish 
embryotoxicity of carbamazepine, diclofenac and 
metoprolol. Ecotoxicology and Environmental Safety 
73(8): 1862-1866. 
Verlicchi, P., Al Aukidy, M. Zambello, E. (2012). 
Occurrence of pharmaceutical compounds in urban 
wastewater: Removal, mass load and environmental 
risk after a secondary treatment: A review, The Science 
of the Total Environment 429(0): pp.123– 155. 
Verslycke, T., Roast, S.D., Widdows, J., Jones, M.B., 
Janssen, C.R. (2004). Cellular energy allocation and 
scope for growth in the estuarine mysid Neomysis 
integer (Crustacea: Mysidacea) following chlorpyrifos 
exposure: a method comparison. Journal of 
Experimental Marine Biology and Ecology 306: pp.1-
16. 
Vigano, et al., 2020. Embryo/larval toxicity and 
transcriptional effects in zebrafish (Danio rerio) 
exposed to endocrine active riverbed sediments. 
Environmental Science and Pollution Research, 27: 
pp.10729-10747. 
Wan, G., Chan, K.M. (2010). A study of somatolactin 
actions by ectopic expression in transgenic zebrafish 
larvae. Journal of Molecular Endocrinology 45: pp.301-
315. 
Weigt, S., Huebler, N., Strecker, R., Braunbeck, T., 
Broschard, T.H. (2011). Zebrafish (Danio rerio) 
embryos as a model for testing proteratogens. 
Toxicology 281: pp.25-36. 
Westerfield, M. (2000). The Zebrafish Book. A Guide for 
the Laboratory Use of Zebrafish (Danio rerio), 4th ed. 
University of Oregon Press, Eugene. 
Xia, L., Zheng, L., Zhou, J.L. (2017). Effects of ibuprofen, 
diclofenac and paracetamol on hatch and motor 
behaviour in developing zebrafish (Danio rerio). 
Chemosphere 182: pp.416-425. 
Yamagami, K. (1981). Mechanisms of hatching in fish: 
secretion of hatching enzyme and enzymatic 
choriolysis. American Zoology 21: pp.459-471. 
Yang, Y., Ok., Y.S., Kim, K-H., Kwon, E.E., Tsang, Y.F. 
(2017). Occurrences and removal of pharmaceuticals 
and personal care products (PPCPs) in drinking water 
and water/sewage treatment plants: A review. Science 
of the Total Environment 596-597: pp.303-320. 
Yonkers, M.A., Ribera, A.B. (2008). Sensory neuron 
sodium current requires nongenomic actions of thyroid 
hormone during development. Journal of 
Neurophysiology 100: pp.2719-2725. 
Zhu, J.J., Xu, Y.Q., He, J.H., Yu, H.P., Huang, C.J., Gao, 
J.M., Dong, Q.X., Xuan, Y.X., Li, C.Q. (2014). Human  
Developmental Anomalies and Oxidative Stress Responses in Zebrafish (Danio Rerio) Following Embryonic Exposure to Human Pharmaceuticals 
Int. J. Toxicol. Environ. Health        125 
 
cardiotoxic drugs delivered by soaking and 
microinjection induce cardiovascular toxicity in 
zebrafish. Journal of Applied Toxicology 34: pp.139-
148. 
Zounkova, R., Odráska, P., Dolezalová, L., Hilscherová, 
K., Marsálek, B., Blaha, L. (2007). Ecotoxicity and 
genotoxicity assessment of cytostatic pharmaceuticals. 





Accepted 10 July 2020 
 
Citation: Aderemi OA, Hunter C, Pahl O, Roberts J, Shu 
X (2020). Developmental Anomalies and Oxidative Stress 
Responses in Zebrafish (Danio Rerio) Following 
Embryonic Exposure to Human Pharmaceuticals. 
International Journal of Toxicology and Environmental 




Copyright: © 2020 Aderemi et al. This is an open-access 
article distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted 
use, distribution, and reproduction in any medium, 
provided the original author and source are cited. 
 
